A carregar...
Use of Mineralocorticoid Receptor Antagonists in Patients With Heart Failure and Comorbid Diabetes Mellitus or Chronic Kidney Disease
BACKGROUND: Perceived risks of hyperkalemia and acute renal insufficiency may limit use of mineralocorticoid receptor antagonist (MRA) therapy in patients with heart failure, especially those with diabetes mellitus or chronic kidney disease. METHODS AND RESULTS: Using clinical registry data linked t...
Na minha lista:
| Publicado no: | J Am Heart Assoc |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5779000/ https://ncbi.nlm.nih.gov/pubmed/29275368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006540 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|